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Gender-responsive:
Health care, treatment and services that are gender-responsive are 
respectful, and informed by knowledge and understanding, of the 
particular lived experiences, inequalities, preferences, concerns and 
needs of individuals based on their distinct genders (or sexes/sex 
characteristics), gender identities and forms of gender expression. 
They also take into consideration the interrelationship between 
gender and a range of other factors (social, economic, etc.) that 
impact on people’s wellbeing.
Harm reduction
Policies, programmes and practices that aim to reduce the harms 
associated with the use of psychoactive drugs among people who 
choose to actively use. For more information, visit: http://www.ihra.
net/what-is-harm-reduction
Needle and syringe 
programme (NSP)
These programmes supply sterile needles/syringes and related 




Prescribed medication supplied to people who use drugs as a 
replacement therapy for opioid dependence. OST decreases or 
eliminates injecting practice among people who use drugs, thus 
significantly reducing HIV and hepatitis C transmission in this 
group, an outcome for which there is a well-established evidence 
base.
Prison
The term “prison” is used throughout this tool to refer to all 
detention facilities. Although the tool does not explicitly focus on 
issues particular to juveniles/youth detention centres, or migrants/
migrant detention centres, it still applies to them.
Prisoner The terms “prisoner” and “detainee” are used interchangeably throughout this tool to refer to adults deprived of their liberty.
Glossary
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ABOUT THIS REPORT
This report is part of the European Union co-
funded project “Improving Prison Conditions by 
Strengthening Infectious Disease Monitoring”, 
led by Harm Reduction International. The 
project aims to reduce ill treatment of people 
in detention and improve prison conditions 
through more comprehensive and standardised 
monitoring of the human immunodeficiency 
virus (HIV), hepatitis C virus (HCV), tuberculosis 
(TB) and harm reduction. The research element 
of the project has two components. The first 
includes mapping the current situation relating 
to HIV, HCV, TB and harm reduction in prisons 
in seven European countries (Greece, Ireland, 
Italy, Latvia, Poland, Portugal and Spain), 
as well as the working practice of human 
rights-based prison monitoring mechanisms 
in these countries, with particular reference 
to HIV, HCV, TB and harm reduction. The 
second research component is the subject 
matter of this report, which maps the existing 
regional and international public health and 
human rights standards relating to HIV, HCV, 
TB and harm reduction in prisons, along 
with the mandate and practice of regional 
and international human rights-based prison 
monitoring mechanisms in this regard.
This research was used to develop a user-
friendly tool, Monitoring HIV, HCV, TB and Harm 
Reduction in Prisons: A Human Rights-Based 
Tool to Prevent Ill Treatment (available on Harm 
Reduction International’s website) to help 
generate better informed, more consistent, 
and sustained monitoring of HIV, HCV, TB 
and harm reduction in prisons by national, 
regional and international human rights-based 
prison monitoring mechanisms, such as the 
European Committee for the Prevention of 
Torture and Inhuman or Degrading Treatment 
or Punishment (CPT), the UN Subcommittee 
for the Prevention of Torture and other 
Cruel, Inhuman or Degrading Treatment or 
Punishment (SPT), and National Preventive 
Mechanisms (NPMs) or National Human 
Rights Institutions. These mechanisms, not 
yet engaged by the harm reduction sector, are 
therefore the main target of this report.
The parameters of this project were purposely 
kept narrow to ensure feasibility. As such, 
the focus is on issues specifically relating 
to HIV, HCV, TB and harm reduction in the 
context of prisons that accommodate adults, 
and the standards that relate to these. 
Juveniles and other places of detention - 
including police cells, psychiatric hospitals 
and immigration detention centres - are not 
specifically addressed in this research. While 
this work certainly remains applicable to these 
populations and settings, they also require 
specific attention, provisions and measures; 
more research and monitoring tools in these 
areas are therefore needed and encouraged.
This report is not meant to be prescriptive, nor 
is it a revision of existing standards on health 
in prisons. It is an overview of prisoners’ health 
rights in relation to HIV, HCV, TB and harm 
reduction, as well as a broader collection of 
minimum standards and guidelines - drawn 
from both the public health and human rights 
fields - than what is normally applied by human 
rights-based prison monitoring mechanisms.
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HIV, HCV, TB and harm reduction in prisons:  
public health and human rights
THE IMPORTANCE Of fOCUSING ON 
HIV, HCV, TB AND HARM REDUCTION 
IN PRISONS:  A PUBLIC HEALTH 
PERSPECTIVE
HIV, HCV and TB epidemics are a major public 
health concern around the world, including 
in high-income countries. Although HIV, 
HCV and TB affect the population at large, 
they have emerged as an especially severe 
problem in prison systems worldwide. Global 
HIV prevalence, for example, is up to 50 times 
higher among the prison population than in the 
general public,1 while one in four detainees 
worldwide is living with HCV,2 in comparison 
to, for example, one in 50 people in the broader 
community in Europe.3 TB is one of the leading 
causes of mortality in many countries’ prisons,4 
with rates up to 81 times higher in prisons 
than in the broader community.5 Prisons 
represent high-risk environments for the 
transmission of these diseases for a number 
of reasons, including the over-incarceration 
of vulnerable and disadvantaged groups who 
are more likely to suffer from poor health; the 
criminalisation of people who use drugs; risky 
behaviour in prisons, such as unsafe injecting 
drug use; substandard prison conditions and 
overcrowding; inadequate health care; and the 
denial of harm reduction services.
Members of poor and marginalised groups 
are overrepresented in the prison population 
worldwide.6 Many of the factors that make 
these groups more likely to be incarcerated, 
including poverty, discrimination and drug 
use, also mean that they tend to carry a 
disproportionately high burden of disease 
and ill-health, including a higher prevalence 
of HIV, HCV and TB. Due to unequal access 
to appropriate health care services prior to 
their incarceration, many begin their prison 
sentence with untreated cases of HIV, HCV 
and TB, while those who enter prison relatively 
healthy have a higher chance of infection for 
several reasons, including increased risky 
behaviour, such as unsafe injecting drug use.
Punitive approaches to drug use have resulted 
in the mass incarceration of people who use 
drugs. According to global figures, 10-48% 
of male and 30-60% of female prisoners are 
using or dependent on illicit drugs upon entry 
to prison,7 and every sixth prisoner is thought 
to be using drugs to a problematic extent.8 In 
Europe, crimes related to the use, possession 
or supply of illicit drugs are the main reason 
for incarceration of between 10% and 25% 
of all sentenced prisoners.9 Despite being 
prohibited, drugs always find their way into 
prisons. While some prisoners stop using and 
injecting drugs during incarceration, others will 
either continue or begin using while in prison.
With people who inject drugs making up about 
one third to one half of prison populations, 
levels of injecting drug use in prisons are high.10 
Despite this reality, however, the provision of 
harm reduction interventions, such as needle 
and syringe programmes (NSPs) and opioid 
substitution therapy (OST), remains extremely 
limited in comparison to what is available in the 
broader community. As of 2015, there are only 
seven countries or territories in the world who 
implement NSPs, while 44 implement OST, in 
at least one prison.11 As needles and syringes 
are so scarce in prison, injecting drug users 
are often forced to make their own injecting 
equipment, and sharing or reusing occurs 
out of necessity. Sometimes up to 15 or 20 
individuals inject with the same equipment,12 
which has been found to be the easiest and 
most effective way of transmitting HIV and 
HCV.13 The combination of high rates of HIV, 
HCV and shared injecting equipment create 
a high-risk environment for the transmission 
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of these diseases. Additional behavioural risk 
factors for the transmission of HIV and HCV 
include consensual and non-consensual 
unprotected sexual activity,14 the sharing or re-
use of tattooing or piercing equipment, and the 
sharing of razors.
Intensifying this risk of infection and related 
ill-health are the substandard prison 
conditions in which prisoners are frequently 
accommodated. Overcrowding, poor sanitary 
conditions, inadequate ventilation and lighting, 
extreme temperatures, inadequate means for 
maintaining personal hygiene, a lack of access 
to clean drinking water, and the provision of 
nutritionally inadequate food are common in 
prisons and contribute to an exceptionally high 
rate of disease and death. Furthermore, these 
poor conditions invariably exist within a climate 
of violence, humiliation and discrimination 
that creates barriers to accessing health care 
services, which are often weak or inadequate 
to being with. With prison health still typically 
falling under the jurisdiction of the Ministry of 
Justice or the Ministry of Interior, rather than 
the Ministry of Health, there is often not only 
a disjunction, but also a marked disparity, 
between the health care provided to prisoners 
and the health care provided to the broader 
community.
Ill health and poor conditions in prisons do not 
just concern detainees and prison staff, they 
are also issues of much wider public concern. 
Illnesses transmitted or exacerbated in prison 
never remain in situ. It is estimated that more 
than 10.2 million people, including sentenced 
and pre-trial detainees, are held in detention 
centres worldwide,15 6 million of which are 
held in Europe alone.16 About one third of 
these return to their communities every year.17 
Because recidivism to prison is common, 
especially among those who have a drug 
dependency,18 there is a high degree of mobility 
between prison and community. Furthermore, 
there is substantial daily interaction between 
prisons and the broader community for prison 
staff and visitors. Prison health, therefore, is 
intimately connected to public health.19 But as 
the following section will demonstrate, it is not 
just a public health concern, it also a human 
rights imperative.
HIV, HCV, TB AND PRISONERS’ 
HEALTH RIGHTS: ENTITLEMENTS AND 
OBLIGATIONS
Under international human rights law, 
prisoners retain all their fundamental rights and 
freedoms during incarceration, except those 
that are unavoidably limited or restricted by the 
fact of their incarceration.20 Like all persons, 
therefore, prisoners have a right to the highest 
attainable standard of physical and mental 
health (hereafter the ‘right to health’).
The cornerstone protection of the right to 
health in international law is found in article 12 
of the International Covenant on Economic, 
Social and Cultural Rights, but several 
provisions found in a range of other, widely 
ratified, human rights treaties also protect 
prisoners’ health rights.21 Some of these 
specifically articulate the right to health,22 while 
others, for example, offer indirect protection, 
such as the prohibition of torture and ill 
treatment, which, as confirmed by the Human 
Rights Committee, engages the right to health 
of all detained persons.23 The right to humane 
treatment imposes positive obligations on 
states to protect the lives and well-being of 
prisoners, which has been interpreted by 
several human rights mechanisms to require 
government authorities to safeguard the 
health of prisoners.24 As will be demonstrated 
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throughout the remainder of this section, the 
right to health and the freedom from torture and 
ill treatment are indivisible and interdependent, 
particularly in prison settings.25
Importantly, the right to health is an inclusive 
right that extends not only to timely and 
appropriate medical care, but also to the 
underlying determinants of health.26 The 
following section identifies some of the 
most relevant entitlements and obligations 
emanating from the right to health of prisoners 
in the context of HIV, HCV, TB and harm 
reduction.
A right to non-discrimination and 
equivalence of care
One of the core obligations of the right to 
health is to ensure “the right of access to 
health facilities, goods and services, on 
a non-discriminatory basis, especially for 
vulnerable and marginalised groups”,27 which, 
as already discussed, includes prisoners. 
Several standards of humane treatment of 
prisoners make reference to the importance of 
non-discrimination in accessing health care,28 
an obligation that is also confirmed in many 
public health declarations and guidelines.29 
In the context of HIV and HCV in prisons, the 
former UN Special Rapporteur on the right to 
health, Anand Grover, has stated that “[i]f harm 
reduction programmes and evidenced-based 
treatment are made available to the general 
public, but not to persons in detention, that 
contravenes international law.”30
Very closely related to the obligation of non-
discrimination is the internationally recognised 
obligation to provide a standard of care in 
prisons that is at least equivalent to that 
available in the community, commonly known 
as the “principle of equivalence”. Some 
experts, however, have questioned whether 
the aim should not be equivalence of care, but 
rather equivalence of objectives and results,31 
which would involve a higher standard of care 
for prisoners. This opinion is supported by the 
European Committee for the Prevention of 
Torture and Inhuman and Degrading Treatment 
or Punishment,32 as well as the former Special 
Rapporteur on the right to health.33
A right to essential medicines
Another important core obligation with regards 
to the right to health of prisoners is the 
provision of essential medicines as defined by 
the World Health Organization (WHO) Essential 
Medicines Programme.34 Essential medicines 
are “those that satisfy the priority health-care 
needs of the population”35 and should be 
available at all times in adequate amounts, in 
the appropriate dosage forms, with assured 
quality, and at an affordable price.36
The WHO’s Model List of Essential Medicines37 
includes morphine, methadone and 
buprenorphine, drugs commonly used to treat 
opioid dependence. These and other drugs on 
the list, such as antiretroviral drugs, are also 
essential for the treatment of HIV, HCV and 
TB, and for pain management and relief. As 
some are classified as “controlled substances” 
under the international drug conventions, 
their availability for medical purposes is 
often excessively limited or restricted despite 
there being no basis for this in international 
law.38 Where these medicines are available 
in the broader community, they tend to be 
of poorer quality, provided sporadically, or 
are simply unavailable in prison settings. As 
the obligation to provide essential medicines 
is to be discharged on a non-discriminatory 
basis, these shortfalls represent a breach of 
international law.39 Indeed, the former Special 
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Rapporteur on the right to health and the 
Human Rights Committee have both confirmed 
there is an obligation on states to ensure that 
people who use drugs deprived of their liberty 
are provided with essential medicines, and that 
the pain and suffering of prisoners associated 
with withdrawal symptoms could amount to ill 
treatment, 40 as found by the European Court 
of Human Rights in McGLinchey and Others 
v UK.41
A right to medical care and treatment
The right to medical care and treatment is 
a critical element of the right to health of 
prisoners. The Committee on Economic, Social 
and Cultural Rights (CESCR) has affirmed that 
“[s]tates are under the obligation to respect the 
right to health by…refraining from denying or 
limiting equal access for all persons, including 
prisoners or detainees … [to] curative and 
palliative health services.”42 This obligation 
is also regularly expressed within civil and 
political rights mechanisms. The Human 
Rights Committee, for example, has confirmed 
that the obligation to “provide appropriate 
medical care to detainees” is engaged 
under article 10 (prohibition of inhuman and 
degrading treatment) of the International 
Covenant on Civil and Political Rights,43 a view 
echoed by the former Special Rapporteur on 
torture, Manfred Nowak.44 Standards relating 
to the treatment of prisoners45 also reflect this 
obligation and the European Court of Human 
Rights has found, on several occasions, that 
inadequate care and treatment for HIV, HCV 
or TB has amounted to cruel, inhuman or 
degrading treatment.46
An important element of this particular right in 
the context of prisons is that of continuity of 
care and treatment. People with health issues 
who move between prison and the community 
can find short periods in prison very disruptive 
to their community-based care and treatment 
programmes. Others who start a particular 
treatment in prison often do not get connected 
with the appropriate aftercare following 
release. This principle is explicitly articulated 
in the revised Standard Minimum Rules for the 
Treatment of Prisoners,47 and enjoys support 
in a number of WHO, UNODC, and UNAIDS 
documents,48 as well as other public health 
standards.49
 
A right to preventive health services, 
including harm reduction
Particularly relevant to the context of infectious 
diseases in prisons is the right to preventive 
health services. The CESCR confirms that “[s]
tates are under the obligation to respect the 
right to health by…refraining from denying or 
limiting equal access for all persons, including 
prisoners or detainees … to preventive…health 
services.50 More specifically, the Committee 
has recommended that states take steps to 
“combat” the spread of diseases in prisons, 
particularly with such serious diseases as TB51 
and HIV.52
The Human Rights Committee has noted that 
“danger to the health and life of detainees as 
a result of the spread of contagious diseases 
and inadequate care amounts to a violation 
of article 10 (prohibition of torture and ill 
treatment)…and may also include a violation 
of articles 9 (right to liberty and security of 
the person) and 6 (right to life).”53 Both the 
former Special Rapporteur on torture54 and 
the European Court of Human Rights55 have 
supported this view, while the European 
Committee for the Prevention of Torture has 
confirmed that, “the act of depriving a person 
of his liberty always entails a duty of care which 
calls for effective methods of prevention”.56 
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This legally binding obligation is also reflected 
in prison health standards,57 WHO58 and World 
Medical Association declarations,59 as well 
as non-binding resolutions of the Council of 
Europe60 and Parliamentary Assembly.61
There is unequivocal evidence confirming that 
one of the most effective ways of preventing 
the spread of HIV and HCV in prisons is through 
the provision of harm reduction services.62 
This has been endorsed by numerous human 
rights63 and public health authorities.64 Navi 
Pillay, the former High Commissioner for 
Human Rights, for example, recognised in 
2009, “the longstanding evidence that a harm 
reduction approach is the most effective way 
of protecting rights, limiting personal suffering, 
and reducing the incidence of HIV” and stressed 
that “this is particularly the case for those in 
detention”.65 Indeed, the provision of harm 
reduction services for people who use drugs is 
now recognised as a component element of the 
right to health and constitutes a legal obligation 
under international human rights law, which 
states must progressively realise.66
A right to the underlying determinants of 
health
According to the CESCR, the right to health is 
an inclusive right that extends not only to health 
care but also to the underlying determinants 
of health, such as “access to safe and potable 
water and adequate sanitation, an adequate 
supply of safe food, nutrition and housing, 
healthy occupational and environmental 
conditions, and access to health-related 
education and information.”67 These and other 
underlying determinants have a considerable 
impact on whether people are healthy or not. 
This is particularly relevant in the context of 
prisons.
The CESCR has identified housing as 
“the environmental factor most frequently 
associated with conditions for disease”, 
pointing out that “inadequate and deficient 
housing and living conditions are invariably 
associated with higher mortality and morbidity 
rates.”68 The Standard Minimum Rules for 
the Treatment of Prisoners also explicitly 
recognise that conditions are integrally linked 
to a prisoner’s health status.69 Furthermore, 
the Committee Against Torture and the 
former Special Rapporteur on Torture have 
consistently argued that inadequate conditions 
of detention could amount to ill treatment,70 
while the European Court of Human Rights has 
found that decline in health, or the contraction 
of disease, while in detention may be judged 
as evidence that the overall prison conditions 
are inhumane or degrading. 71
A right to participation 
The right to participation, the basic right of 
people to have a say in matters that affect 
their lives, has been described as the “right 
of all rights”.72 The CESCR and the former 
special Rapporteur on the right to health, 
Paul Hunt, have identified participation in 
all health-related decision-making at the 
community, national and international level as 
an important component of the right to health, 
as well as one of the underlying determinants 
of health.73 Importantly, individuals have a 
right to ‘active and informed’ participation, 
which relies on institutional arrangements and 
specific mechanisms to ensure participation at 
different stages, as well as capacity-building 
activities to ensure that people have the ability 
to meaningfully and effectively participate.74 
In this context, informed participation relies in 
part on the right to seek, receive and impart 
health-related information and the right to 
basic health education.
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The WHO, UNODC and UNAIDS have 
recognised the importance of prisoner 
participation in the context of the development 
and implementation of policies and initiatives 
to address HIV in prisons.75 There is also 
recognition of the value of prisoner participation 
in health matters within the Council of 
Europe76 and the European Committee for the 
Prevention of Torture.77 Importantly, significant 
benefits to people’s participation in health 
decisions have been identified, including 
increased sustainability and effectiveness 
of interventions, improvements in health 
outcomes and the quality of health care and 
services, empowerment of individuals and 
enhanced accountability.78
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Minimum standards relating to HIV, HCV, TB and 
harm reduction in prisons
WHAT ARE MINIMUM STANDARDS AND 
HOW ARE THEy USED?
Standards are typically understood as 
agreements on appropriate or desirable levels 
of quality or attainment. In the field of public 
health, they generally derive from evidence or 
best practice. In the context of human rights, 
standards are derived from the law and help 
outline the necessary minimum pre-conditions 
for compliance with legal requirements. 
For example, while prisoners’ health rights 
are protected by law, the law itself does not 
provide sufficient clarity in terms of what 
exactly is required of states to meet their 
obligations in relation to a particular right. 
By defining some of the specific steps and 
benchmarks required to respect, protect and 
fulfil human rights, standards help to ensure 
state responsibility and accountability in a 
structured way. They are also very useful tools 
for monitoring state compliance with their 
human rights obligations. It is important to 
note, however, that while meeting standards is 
often a necessary pre-condition for compliance 
with legal requirements, they only provide 
a minimum level of protection. Authorities, 
therefore, should strive to provide conditions 
that exceed the minimum standards identified 
in this report and elsewhere.
Some standards, like the absolute ban on 
torture and ill treatment and the obligation 
to respect the right to health by refraining 
from denying or limiting equal access for all 
persons to health services, are protected by 
international and regional treaties, as well as 
national constitutions and laws. Other public 
health and human rights standards, like those 
included in the UN Standard Minimum Rules 
for the Treatment of Prisoners, codify much 
more specific entitlements and obligations 
with regards to, for example, adequate medical 
care for persons in detention. While the latter 
do not formally enjoy the status of international 
law, and are technically non-binding “soft law” 
instruments, a strong argument, can be made 
that they have become accepted minimum 
legal requirements for governments to meet.79
MINIMUM STANDARDS RELATING TO 
HIV, HCV, TB AND HARM REDUCTION IN 
PRISONS
The following standards have been identified 
as some of the most significant for preventing, 
treating, and caring for HIV, HCV and/or TB in 
prisons in a human rights compliant manner. 
They are not new, but rather derive from 
pre-existing standards from both the human 
rights and public health fields. Some may look 
unfamiliar to health professionals because a 
human rights angle has been added, and the 
reverse is also true.
They were selected by carefully combing 
through human rights treaties, declarations, 
general comments, commitments, 
recommendations, rules, principles, policy 
papers, reports, regional and international 
judicial decisions, standards on humane 
treatment, monitoring body reports, and public 
health guidelines and best practice relating to 
HIV, HCV, TB, drug use, harm reduction, and 
human rights in prisons.
The first five sections focus specifically on 
issues identified as the most pressing and 
currently overlooked with regards to the 
prevention of ill treatment in the context of 
HIV, HCV, TB and harm reduction in prisons. 
The remaining sections identify standards 
relating to HIV, HCV, TB and harm reduction 
with regards to national context (sections 6-8), 
the prison health system (sections 9-16), and 
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accountability for prisoners’ health and human 
rights (sections 17-19).
Importantly, the standards that follow 
incorporate a human rights-based approach 
to health, which aims to realise the right to 
the highest attainable standard of physical 
and mental health and other health-related 
rights within prisons. It is based on seven key 
principles: participation, equality and non-
discrimination, accountability, and availability, 
accessibility, acceptability and quality of 
facilities goods and services. These principles 
should guide not only service delivery, but 
also programming in all health-related sectors 
and at all stages of the process. A human 
rights-based approach to health is not only 
about the achievement of certain goals or 
health outcomes, it is about their achievement 
through a participatory, inclusive, transparent 
and responsive process.
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1. PREVENTION/HARM REDUCTION SERVICES
a) All prisoners should have equal, easy and confidential access to sterile injecting 
equipment through needle and syringe programmes. Prisoners and staff should receive 
information and education about the programmes and be involved in their design and 
implementation.
b) Needle and syringe programmes should be available at relevant times to meet the needs 
of prisoners, should be accessible on a confidential basis, and be offered free of charge.
c) All prisoners should have equal, free, easy and discreet access to condoms and 
lubricants. These should be available at all times, in various locations, and without 
prisoners having to request them.
d) Women should have equal, free, easy, and discreet access to female condoms.
e) Post-exposure prophylaxis should be offered to all prisoners and staff for exposure that 
has the potential for HIV transmission. This must be initiated within 72 hours.
f) Pregnant women should have access to the full range of interventions for the prevention 
of mother-to-child transmission, including family planning and antiretroviral prophylaxis 
for pregnant and breastfeeding women.
g) Prisoners should have access to the materials necessary for sterile tattooing and 
piercing.
h) All preventive/harm reduction services should be relevant to the needs of individual 
prisoners.
i) Naloxone should be available within prisons to reverse opioid overdoses.
2. EVIDENCE-BASED DRUG DEPENCENCE TREATMENT AND CARE
a) Prisoners should have access to the same evidence-based drug dependence treatment 
and counselling programmes that are available to the broader community.
b) Prisoners should have equal, easy, confidential, and uninterrupted access to opioid 
substitution therapy (OST) during their detention. 
c) OST should be available on a voluntary basis, free of charge, gender-responsive, and 
accompanied by relevant information and support.
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d) Prisoners should be involved in developing their own treatment plans.
e) Detoxification programmes should be available to prisoners on a voluntary and 
confidential basis, and should be supervised by trained health professionals.
f) Prisoners participating in drug dependence programmes should have access to 
counselling and psychosocial services.
g) Prison health services should provide or facilitate, if necessary, specialised drug 
treatment programmes designed especially for women.
h) A functioning system of referral and cooperation between medical services inside and 
outside prisons should be in place to ensure continuity of drug dependence treatment 
between correctional institutions and jurisdictions, and following release.
3. HIV TREATMENT AND CARE
a) At each stage of HIV-related illness, prisoners should receive appropriate medical 
and psychosocial treatment at least equivalent to that given to other members of the 
community.
b) Treatment for HIV should be provided by prison medical services, applying the same 
quality, clinical and accessibility criteria as in the broader community.
c) Authorities should ensure that prisoners are provided with accessible information on HIV 
treatments and therapies sufficient to enable them to make an informed choice about 
their treatment options, and that they are able to refuse treatment if they so choose.
d) HIV treatment and care should be gender-responsive.
e) Authorities should ensure that prevention, diagnosis and treatment of STIs, TB, hepatitis 
and other opportunistic infections are provided as key components of comprehensive 
HIV care.
f) Prisoners should have access to diagnostics, antiretroviral treatment, a proper diet, 
health promotion options, and adequate pain management medications.
g) Prisoners should have access to effective, appropriate, and compassionate palliative 
care that meets standards available in the wider community.
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h) Antiretroviral therapy should be provided to prisoners to reduce the progression, 
mortality and transmission of the disease.
i) Post-exposure prophylaxis (PEP) should be offered on a confidential basis and within 72 
hours, to all prisoners and staff for exposure that has the potential for HIV transmission.
j) Antiretroviral prophylaxis should be available to pregnant prisoners to prevent mother-
to-child transmission.
k) The medicine necessary for HIV treatment should be of good quality.
l) All prisoners undergoing HIV treatment should be offered support services, including 
counselling.
m) Options for the early release of prisoners with advanced stages of HIV-related illness 
should be available.
n) All costs associated with HIV treatment and care should be covered by the state or the 
prison authorities.
o) A functioning system of referral and cooperation between medical services inside and 
outside the prison should be in place to ensure continuity of HIV treatment and care 
between correctional institutions and jurisdictions, and following release.
4. HCV TREATMENT AND CARE
a) All prisoners living with HCV should be evaluated for the presence or severity of liver 
damage and the need for treatment.
b) All prisoners living with HCV should be vaccinated for hepatitis A and B if not already 
protected, to prevent co-infection.
c) All prisoners living with HCV should be provided with the most up-to-date and evidence 
based treatment.
d) All prisoners living with HCV should be provided with sufficient accessible information 
on HCV treatment and therapies to enable them to make an informed choice about their 
treatment options.
e) HCV treatment and care should be gender-responsive.
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f) All costs associated with HCV treatment and care should be covered by the state or the 
prison authorities.
g) The medicine needed to treat HCV should be of good quality.
h) There should be a functioning system of referral and cooperation between medical 
services inside and outside the prison in place to ensure continuity of HCV care and 
treatment between correctional institutions and jurisdictions, and following release.
5. TB TREATMENT AND CARE
a) TB treatment should be initiated immediately upon detection to interrupt transmission 
and prevent emergence of drug resistance.
b) Drug susceptibility testing should be performed at the start of treatment for all previously 
treated TB patients.
c) All prisoners found to have infectious TB should be isolated, in a human rights-compliant 
way, in properly ventilated facilities while contagious.
d) All prisoners should receive adequate treatment in line with national TB programme 
guidelines, including for those with multiple drug-resistant TB and TB-HIV co-infection, 
using directly observed treatment, short-course (DOTS) and an uninterrupted supply of 
drugs of guaranteed quality.
e) Prisoners with multiple drug-resistant TB should be treated with specialised regimens 
containing second-line anti-tuberculosis drugs.
f) TB treatment and care should be gender-responsive.
g) TB treatment should be administered under the direct observation of health care staff in 
line with national TB programme guidelines.
h) All prisoners undergoing TB treatment should be offered support services, including 
counselling.
i) Voluntary HIV testing and counselling should be part the routine management of all TB 
patients.
j) All costs associated with TB treatment and care should be covered by the state or prison 
authorities.
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k) All prisoners receiving TB treatment should be provided with sufficient accessible 
information on TB treatments and therapies to enable them to make an informed choice 
about their treatment options, and refuse treatment if they so choose.
l) A functioning system of referral and cooperation between medical services inside and 
outside the prison should be in place to ensure continuity of TB treatment and care 
between correctional institutions and jurisdictions, and following release.
6. POLICy MEASURES
a) Policies and guidelines on communicable diseases should be devised at the national level.
b) Authorities should devise policies or guidelines for the prevention, care and treatment 
of HIV, HCV and TB.
c) Authorities should draw up a comprehensive drug policy for prisoners which incorporates 
harm reduction and evidence-based drug treatment.
d) All health related policies, at the national and prison level, should be based on evidence 
and best practice.
e) All prison health policy should be informed by the assessed needs of the specific prison 
population.
f) The specific needs of key groups that are most at risk, including women, people who 
inject drugs and sex workers, should be taken into account in prison health policies and 
guidelines.
g) Representatives of the prison sector should meaningfully participate in the development 
prison health policies and guidelines.
h) Former and current prisoners, or appropriate representatives, should meaningfully 
participate in the development and implementation of all policies and guidelines relating 
to their health.
7. RESOURCES
a) Adequate financial and human resources should be made available within the prison 
health system to adequately address HIV, HCV and TB.
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b) National authorities should increase prison health budget allocations.
c) Funding and resources for interventions that demonstrate a needs and evidence base, 
such as harm reduction interventions, should be prioritised.
8. INTEGRATION AND EQUIVALENCE
a) Medical services in prisons should be organised in close relation with the general health 
administration of the community or nation.
b) Health policy in prisons should be integrated into, and compatible with, national health 
policy.
c) Prison health services should be integrated into public health structures and collaboration 
between public health, social services, drug services and prison health systems and 
staff should be enhanced.
d) National programmes on HIV, HCV and TB should consider prisons when planning and 
budgeting.
e) Prisoners are entitled to at least the same standards of health care that are available in 
the broader community during their incarceration.
9. PRISON CONDITIONS
a) Every prisoner should be provided with food at the usual hours which satisfies in quality 
and quantity the standards of diet and modern hygiene and takes into account their age, 
health, the nature of their work, and so far as possible, religious or cultural requirements.
b) Drinking water should be available to every prisoner whenever it is needed.
c) Prisoners should always have access to natural light and fresh air (ventilation) in the 
places where they are required to live and work.
d) Every prisoner should have ready access to proper toilet and sanitation facilities, as well 
as the ability to maintain good standards of personal hygiene.
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e) Temperatures should be regulated to suit the climate of the season in places where 
prisoners are required to live, work and bathe.
f) Prisoners’ clothing and bedding should be changed and washed regularly, so that these 
are in clean and good condition.
g) Each detainee must have an individual mattress and bedframe in the cell, and be able to 
move freely between the furniture.
h) All prisoners should have access to regular outdoor exercise.
i) Prisoners and staff should be ensured protection from discrimination on all prohibited 
grounds including sex, gender, race, ethnicity, sexual orientation, and health status.
10. MEDICAL SCREENING
a) All prisoners must be seen by a fully qualified health professional to assess their health 
and medical needs within 24 hours of arrival into custody.
b) The initial medical examination should be systematic, comprehensive, and use up-to-
date methods. It should include a physical examination, screening for TB, screening for 
potential withdrawal symptoms resulting from the use of drugs, medication or alcohol, 
and voluntary, confidential and free testing for HIV and HCV.
c) All examinations should be accompanied by relevant information, including information 
on the objectives of each exam/test, communicable disease prevention, and safer drug 
use and sex. If free and informed consent is given for voluntary tests, appropriate pre- 
and post-test counselling should be provided.
d) All medical examinations should be conducted out of the hearing of prison officers and 
all patient-related information, including test results, should be protected by medical 
confidentiality.
11. EDUCATION AND INfORMATION
a) Prisoners should be given a leaflet or booklet on their arrival informing them of the 
existence and operation of health care services.
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b) All prisons should have a health education programme in place, which includes education 
on healthy lifestyles (nutrition, exercise, smoking, safer behaviour and practices) and 
mental health promotion.
c) A prison health care service should ensure that accurate and non-judgemental 
information about HIV, HCV and TB, including methods of transmission, means of 
protection, and the application of adequate preventive measures, is regularly circulated 
to prisoners and prison staff.
d) Health information should be coordinated and consistent with that disseminated in the 
general community, and all prisoners should have an opportunity to discuss the related 
information with qualified people.
e) Prisoners should have the opportunity to participate in the development of health 
education programmes and materials.
f) All written materials distributed to prisoners should be appropriate for the educational 
level in the prison population. Information should be made available in a language and 
form that prisoners can understand, and presented in an attractive and clear format.
g) Information and counselling should be provided to prisoners who use drugs to promote 
harm reduction and to facilitate their access to appropriate harm reduction services.
h) The content and message of educational materials relating to HIV, HCV and TB should 
respect and be relevant to differences in, for example: sex, gender, gender identity, 
health status, age, race, ethnicity, culture, religion, language, literacy level, and sexual 
orientation.
i) The content of health education programmes for prisoners should combat HIV 
related discrimination, homophobia and any stigma associated with same-sex sexual 
relationships, and discrimination and stigma associated with sex work and drug use.
j) Prisoners and prison staff should be involved in disseminating information (peer 
education) on communicable diseases and harm reduction.
12. INfORMED CONSENT
a) Every prisoner is free to refuse treatment or any other medical intervention.
b) Prisoners should be informed of their right to refuse before any medical intervention.
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c) In order to be able to provide informed consent, prisoners should be informed of the 
clinical and prevention benefits of testing for HIV, HCV and TB, the objectives of every 
medical exam or test, as well as the follow-up services that will be available to them.
d) Prisoners should be provided with all relevant information concerning their condition, 
the course of the treatment and medication prescribed to them.
e) Prisoners who refuse any medical interventions should not be subjected to disciplinary 
measures, i.e. segregation.
13. MEDICAL RECORDS
a) Forms should be designed for recording all prisoner medical examinations. The forms 
should include a record of the prisoner’s name, age and cell number; the doctor’s name; 
the date, time and focus of all examinations; a record of the prisoner’s infectious disease 
and vaccination history; and diagnostic information.
b) All medical records should be securely held to protect the patient’s right to confidentiality. 
Only medical personnel should have access to prisoner medical files.
c) Prisoners should be able to access and/or obtain a copy of their medical files upon 
request.
d) In the event of a transfer, medical files should be forwarded to the doctors in the receiving 
establishment.
e) Upon release, prisoners’ medical information should be forwarded to the community 
doctor of their choice.
f) Protocols should be in place to ensure secure information sharing between service 
providers in the community and in prisons.
14. MEDICATION
a) Prisoners should receive a regular, uninterrupted supply of the essential medicines 
required for their treatment.
b) Prisoners should have access to all the medicine included in the WHO list of essential 
medicines, including methadone, buprenorphine, naloxone and antiretrovirals.
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c) Qualified staff should be available to ensure that prisoners take the prescribed medicines 
in the correct doses and at the correct intervals.
d) Only qualified health care staff members should dispense medicine.
e) The state or prison authorities should cover the purchase of any medication.
f) All medication should be of good quality, and stored in appropriate locations and at 
appropriate temperatures.
15. GENERAL TREATMENT AND CARE
a) Prisoners should receive the same quality of care, treatment and support as persons 
living in the broader community.
b) All prisoners should have access to a member of the health care staff at any time, 
regardless of their type of detention.
c) Prisoner requests to consult a doctor should be met without undue delay.
d) Prisoner requests to be examined by a health care staff member of the same sex or 
gender should be respected.
e) Prisoners in need of diagnostic examination and/or hospital treatment should be 
promptly transferred to appropriate medical facilities.
f) Prisoners should be involved in planning their own care and treatment.
g) Women should receive the same standard of care and treatment as men.
h) Gender-responsive health care services at least equivalent to those available in the 
broader community should be available to prisoners who need them.
16. PRISON STAff (HEALTH CARE AND CUSTODIAL)
a) Prison staff should receive HIV, HCV and TB prevention information during their initial 
training and thereafter on a regular basis.
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b) National authorities should develop specialised courses for staff that provide health care 
services in prisons, covering topics such as communicable diseases, harm reduction, 
epidemiology, hygiene, and medical ethics and human rights, including the right to 
health and freedom from ill treatment.
c) Prison authorities should support the training of health care staff leading to a recognised 
qualification for professionals responsible for the prevention and reduction of health-
related risks associated with drug use.
d) Prisoners should be treated by staff who receive regular and ongoing training, 
supervision and support to maintain their professional registration, and who continue 
their professional development. Staff credentials should be regularly checked.
e) All prison staff should receive gender-responsive training.
f) Health care staff should be integrated into the public health service, including with 
regard to access to goods, services, information and training.
g) Health care staff should be independent from the prison system.
h) Working hours of medical staff should be appropriate to the needs of the prison.
i) Members of health care staff should be on duty day and night, and on weekends.
j) All staff should receive domestically competitive salaries and benefits, and should be 
allowed to have a healthy work-life balance.
17. MONITORING 
a) Authorities should establish mechanisms to oversee, supervise and inspect the 
administration of prisons, including in relation to health.
b) A routine health data collection system should be in place that collects, among other 
things, disaggregated data on HIV, HCV and TB in prisons.
c) Indicators and benchmarks measuring compliance with, and progress towards, human 
rights and public health standards should be developed for all interventions relating to 
HIV, HCV and TB harm reduction.
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d) The implementation of any form of intervention relating to HIV, HCV or TB should be 
accompanied by precise studies monitoring progress and evaluating effectiveness, 
while taking into consideration informed consent, confidentiality, respect for human 
rights, available scientific evidence and scientific integrity.
e) Health indicators should be disaggregation on the prohibited grounds of discrimination 
to identify any particular or intersecting disparities in levels of enjoyment of the right to 
health and to ensure appropriately targeted interventions. 
f) All measures should be taken to ensure that human rights violations do not inadvertently 
occur in the process of data collection, i.e. discrimination or violation of confidentiality 
and consent.
g) Prisoners should participate in the monitoring and evaluation of all health-related 
interventions.
18. REVIEW
a) There should be easily accessible and confidential avenues for prisoners to make 
comments/complains about their health care and treatment, and systems should be in 
place to support those who may need assistance in doing this.
b) Responses to health-related complaints should be timely, easy to understand, dealt with 
by a health professional and deal directly with the prisoner’s concerns.
c) Prisoners who make complaints against staff or other prisoners should not be 
discriminated against and must be protected from possible recrimination.
19. REMEDIES
a) Mechanisms and institutions should be empowered to provide remedies to prisoners in 
the event of violations of health or other rights.
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Monitoring HIV, HCV, TB and harm reduction in 
prisons
The journey from standard setting to effective 
implementation or operationalisation is often 
a long and difficult one. Prisons are rarely the 
subject of public attention or concern, not 
only because they are closed settings, making 
them difficult to monitor, but also because they 
accommodate individuals and groups that 
tend to be stigmatised by the rest of society. 
The lack of public attention to prison issues 
makes it very easy for governments to ignore 
their obligations and violate prisoners’ rights.80 
This is where the work of independent prison 
monitoring bodies, such as the European 
Committee for the Prevention of Torture 
and Inhuman or Degrading Treatment or 
Punishment (CPT) and the UN Subcommittee 
for the Prevention of Torture and other 
Cruel, Inhuman or Degrading Treatment or 
Punishment (SPT), and National Preventive 
Mechanisms (NPMs) is crucial. Empowered 
with extensive mandates to prevent torture and 
ill treatment,81 and granted unrestricted access 
to people and information, the CPT, SPT and 
NPMs visit places of detention the world over 
to examine whether conditions of detention are 
in conformity with minimum standards. In the 
context of HIV, HCV, TB and harm reduction, 
which are increasingly found to engage the 
right to be free from torture and ill treatment, 
there is an important role for such monitoring 
bodies to play. The following section explores 
the current mandates and working practice 
of the CPT and SPT, particularly in relation to 
HIV, HCV, TB and harm reduction in prisons, 
to assess the degree to which they can and 
do consider matters relating to these issues in 
their work, as well the important role they can 
and ought to play in improving prisoners’ health 
in the course of their work. For an evaluation of 
the work of national monitoring bodies in this 
respect, please see the reports produced by 
our national partners in this project.*
*  These reports are available on the Harm Reduction International website.
THE CPT AND SPT: MANDATES AND 
WORkING METHODS
The CPT was established under the European 
Convention for the Prevention of Torture 
and Inhuman or Degrading Treatment or 
Punishment, which came into force in 1989 
and has since been ratified by all 47 member 
states of the Council of Europe. It is not an 
investigative body, but rather “provides a 
non-judicial preventive mechanism to protect 
persons deprived of their liberty against 
torture and other forms of ill-treatment” in 
Europe.82 The CPT’s mandate is set in Article 
1 of the Convention, which provides that 
“[t]he Committee shall, by means of visits, 
examine the treatment of persons deprived 
of their liberty with a view to strengthening, 
if necessary, the protection of such persons 
from torture and from inhuman or degrading 
treatment or punishment”.83
The Committee currently consists of 47 
members, one from each state that has ratified 
the Convention. Each member is elected 
by the Council of Europe’s Committee of 
Ministers, and serves a four-year term with 
the possibility of being re-elected only once.84 
The Convention affirms that the members 
much be chosen “from among persons of 
high moral character” and must be “known 
for their competence in the field of human 
rights or having professional experience in 
the areas covered by this Convention.”85 The 
members, who are independent and impartial, 
include experts from a variety of backgrounds, 
including medical professionals, lawyers, 
human rights practitioners, and specialists in 
prison or police matters.
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The CPT implements its preventive function 
through periodic and ad hoc visits to places 
of detention. It enjoys unlimited access to all 
places of detention, as well as all information 
and documents, and is entitled to conduct 
private interviews with detainees and to 
communicate freely with anyone whom it 
believes can supply relevant information, 
including lawyers and medical doctors. 
Delegations comprised of two to five members 
are formed for each visit or mission, and 
efforts are taken to ensure a gender and 
professional balance.86 The Committee may 
also be assisted by experts, including medical 
experts, on an ad hoc basis to provide 
particular or specialised skills, in addition to 
those of the Committee members. In practice, 
experts have accompanied almost all the 
CPT’s missions, and there are on average two 
experts per delegation.87 Visits are typically 
organised around the examination of a few 
substantive issues, including treatment of 
prisoners, conditions of detention, and health 
care services. In its 3rd General Report, the CPT 
explicitly affirmed that “[h]ealth care services 
for persons deprived of their liberty is a subject 
of direct relevance to the CPT’s mandate.”88 
When visiting prison health care services, 
the CPT is typically guided by consideration 
of: access to a doctor, equivalence of care, 
consent and confidentiality, preventive health 
care, humanitarian assistance, as well as 
professional independence and competence.89
All CPT visits must be followed up by an 
analysis of the problems encountered and 
recommendations to resolve them, which 
are incorporated into a report. While these 
recommendations are not legally binding, 
under the principle of cooperation, states are 
required to give them serious consideration 
and to try to implement them as far as possible. 
States are also required to formally respond 
to the Committee’s report. Furthermore, six 
months after receiving the report, the state 
must generally submit an interim report, and 
within one year it must send in a follow-up 
report on the measures taken to implement 
the recommendations. In this way an on-
going dialogue is established between the 
Committee and the authorities with the aim of 
improving the conditions of detention as well 
as the treatment of people deprived of their 
liberty.90
The SPT started operating in February 2007, 
having been established by the Optional 
Protocol to the Convention Against Torture 
(OPCAT), which entered into force in 2006 and, 
as of January 2016, is ratified by 80 countries. 
Like the CPT, it is not an investigative body, but 
is rather “focused on an innovative, sustained 
and proactive approach to the prevention 
of torture and ill treatment.”91 Also like the 
CPT, it is mandated to undertake regular 
visits to places where people are deprived of 
their liberty and make recommendations to 
states concerning the protection of persons 
deprived of their liberty against torture and ill 
treatment.92 Unlike the CPT, however, it also 
has another important function, which is to 
advise and provide assistance to states parties 
on the establishment of National Preventive 
Mechanisms (NPMs), which OPCAT requires 
that they establish, as well as provide advice 
and assistance to both the NPMs and state 
parties regarding the working of the NPM. 
In addition, the SPT must cooperate, for the 
prevention of torture in general, with relevant 
UN organs and mechanisms, as well as with 
international, regional and national institutions 
and organisations.93
The SPT currently consists of 25 independent 
and impartial experts from various regions of 
the world, that are elected by states parties 
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to the OPCAT for one four-year term, with the 
possibility of being re-elected once. Like the 
CPT, members come from a wide variety of 
professional backgrounds, including health, 
law and human rights.
Similar to the CPT, the SPT visits places of 
detention to examine whether or not conditions 
of detention are in conformity with the relevant 
national and international minimum standards. 
It has unrestricted access to all places where 
people may be deprived of their liberty, their 
installations and facilities and to all relevant 
information. They can also privately interview 
persons deprived of their liberty and any other 
person who might be able to provide relevant 
information. They also undertake NPM and 
OPCAT advisory visits, during which guidance 
is provided with regards to establishing a NPM 
and their effective operational practices, etc. All 
visits are conducted by at least two members 
of the SPT, accompanied, if necessary, by 
experts with relevant professional experience 
and knowledge. In the SPT’s visit guidelines, 
it is specifically stated that the delegation shall 
consist of at least one lawyer and one medical 
doctor.94
During each of its visits to date, the SPT 
has looked at issues relating to health care 
and conditions of detention. After each 
visit, a report is drawn up and concrete 
recommendations are made to assist the state 
party in improving conditions and protection 
against torture and ill treatment. Again, these 
recommendations are not legally binding, but 
States are expected to begin implementing 
them just as soon as possible. In some cases, 
the SPT conducts follow-up visits to check on 
the progress being made in relation to their 
recommendations.
Overall, both the CPT and SPT have demo-
nstrated that prisoners’ health is a priority. 
Not only does each body consist of medical 
experts and examine issues relating to 
health and the underlying determinants of 
health during each visit, but both have also 
established ad hoc working groups on medical 
issues. Considering this, it is certainly within 
the mandate and capacity of both the CPT and 
SPT to look at the inter-related issues of HIV, 
HCV TB, harm reduction and ill treatment in 
places of detention. The following section will 
evaluate the extent to which they do in practice, 
the coherence of any recommendations made 
and standards promoted in relation to these 
issues, and the role both mechanisms could 
play in the promotion of prisoners health and 
human rights by focusing more of their efforts 
on HIV, HCV, TB and harm reduction while 
fulfilling their preventive mandates.
CPT AND SPT MONITORING PRACTICE 
IN THE CONTExT Of HIV, HCV, TB AND 
HARM REDUCTION
The CPT and SPT have similar mandates 
and working methods, which enable them to 
prioritise prisoners’ health in their work. The 
two bodies have, however, differed in their 
attention and approach to HIV, HCV, TB and 
harm reduction in places of detention. Although 
both bodies have identified the transmission of 
these diseases as a serious problem in prisons 
and consistently look at issues that relate to 
health and have a bearing on communicable 
diseases, the CPT has devoted much more 
attention to HIV, HCV, TB and harm reduction 
in both the standards it has developed over 
the years, as well as in its recommendations. 
This is certainly partially due to the fact that 
it has been in operation for much longer, has 
undertaken many more visits and has a more 
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focused mandate. Nevertheless, more could be 
done by both monitoring bodies to contribute 
to the prevention of ill treatment in the context 
of HIV, HCV, TB, and harm reduction, while 
improving prisoners’ health and enjoyment of 
human rights in the process.
The CPT has explicitly recognised that the 
transmission of HIV, HCV and TB is a serious 
problem in certain prison systems.95 On several 
occasions, it has expressed serious concerns 
about the inadequacy of the measures taken 
to tackle this, as well as the conditions under 
which prisoners are held, which the Committee 
has “found to be such that they can only favour 
the spread of these diseases.”96 In light of its 
findings and drawing from existing regional 
and international standards, the CPT has 
developed several standards of its own, some 
of which specifically address HIV, HCV, and TB. 
For example, it has affirmed that, regardless of 
economic difficulties, “the act of depriving a 
person of [their] liberty always entails a duty 
of care which calls for effective methods of 
prevention, screening and treatment.”97 It has 
explained that,
The use of up-to-date methods for 
screening, the regular supply of 
medication and related materials, 
the availability of staff ensuring 
that prisoners take the prescribed 
medicines in the right doses at the 
right intervals, and the provision 
when appropriate of special diets, 
constitute essential elements of 
an effective strategy to combat 
[HIV, HCV, and TB] and to provide 
appropriate care to the prisoners 
concerned.98
In order to dispel misconceptions surrounding 
communicable diseases, the CPT has made it 
clear that national authorities are also obliged 
to ensure that there is a full educational 
programme about them, in particular HIV, 
HCV and TB, for both prisoners and prison 
staff that addresses methods of transmission, 
means of protection, and the application of 
adequate preventive measures.99 The CPT 
has also affirmed that appropriate information 
and counselling should be provided before 
and, in the case of a positive result, after any 
screening test, and that non-discrimination, 
confidentiality and informed consent should 
always be taught, promoted and respected.100 
With regards to the underlying determinants 
of health, the CPT has stated that conditions 
of accommodation for prisoners with 
communicable diseases must be conducive to 
the improvement of their health, and authorities 
must ensure natural light, good ventilation, 
satisfactory hygiene and the absence of 
overcrowding. In order to ensure that HIV, HCV 
and TB are effectively controlled, everyone 
working in this field in a given country must 
co-ordinate their efforts as best as possible. 
In this respect, the CPT has stressed that the 
continuation of treatment after release from 
prison must be guaranteed.101 These and other 
standards more generally related to health, 
such as the ability to access a doctor at any 
time, are raised continuously throughout the 
CPT’s reports.
The CPT has also made several recom-
mendations regarding drug policies and harm 
reduction in prisons, which have a significant 
bearing on the prevention of HIV and HCV. In 
2002, it drafted a list of issues to be examined 
when evaluating arrangements for the 
treatment of drug users detained in prisons, 
which includes considerations of equivalency, 
availability and accessibility of harm reduction 
services and continuity of care.102 On a number 
of occasions it has called upon authorities to 
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draw up a comprehensive strategy for the 
provision of assistance to prisoners with 
“drug-related problems” and to institute a 
harm reduction policy.103
After visiting detention facilities in Ireland, 
the CPT recommended that “all prisoners 
admitted while on methadone maintenance 
programmes in the community should be able 
to continue such maintenance within prisons 
as part of a comprehensive drug treatment 
programme” and that “prisoners undergoing 
drug withdrawal should be provided with the 
necessary support to alleviate their suffering.”104 
Following up on this recommendation four 
years later, the CPT observed that in one 
prison visited, “the prison doctor…refused 
to provide methadone treatment and that 
the “methadone doctor” only visited twice a 
week resulting in a haphazard and incomplete 
treatment programme,” and recommended 
that authorities take the necessary steps to 
remedy these deficiencies.105 The CPT has also 
stressed that management of prisoners who 
use drugs must be varied – combining harm 
reduction and detoxification programmes, 
substitution therapy, psychological support, 
socio-educational programmes and 
rehabilitation.106 Attention has also been drawn 
to the importance of providing specific training 
on drug-related issues to all health care and 
prison staff.107
In contrast to the CPT’s rather detailed 
attention to HIV, HCV and TB and other issues 
that specifically increase the risk of their 
transmission, the SPT has not yet turned its 
attention to these in a comprehensive way. 
When considering issues of health care, 
the SPT has tended to focus on medical 
examinations on arrival, conditions of 
detention (including food, sanitation, drinking 
water and hygiene), cost of services and 
medication, availability and training of doctors, 
specialised care for women, pregnant women 
and children, and medical confidentiality. While 
these are important and clearly relevant to HIV, 
HCV and TB, specific focus on these diseases 
has been minimal.
The SPT has stated that medical examinations 
upon admission are extremely important, first, 
as a safeguard against ill treatment, but also 
because they “provide a good opportunity to 
assess the state of health and medical needs 
of prisoners, to carry out voluntary tests and to 
offer advice on sexually transmitted diseases 
as well as information on the prevention of 
such diseases and other infectious diseases 
or drug addition.”108 In the context of HIV, the 
SPT has recommended that all prisoners be 
provided with a free and voluntary HIV test, 
which should be confidential, accompanied 
by advice and be administered only with the 
prisoners’ informed consent.109 In the context 
of TB, the SPT has recommended that all 
prisoners should have the opportunity to be 
X-rayed for TB using mobile X-ray units and 
that treatment should commence for inmates 
who have tested positive.110 Echoing the CPT, 
the SPT has also recommended that the state 
authorities develop specialised courses on, 
among other things, communicable diseases 
for physicians who provide medical services in 
prisons.111 Following its visit to the Maldives, 
the SPT remarked that since most prisoners 
were sentenced for drug related crimes, 
authorities should introduce programmes 
for treatment and rehabilitation of “drug 
abusers”.112 Aside from these examples, there 
is rarely any attention paid to HIV, HCV and TB 
or issues relating to drug use or harm reduction 
in prisons. And it is worth observing that 
while the CPT refers to several human rights 
and public health documents when reporting 
on health, the SPT refers to the Standard 
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Minimum Rules for the Treatment of Prisoners, 
which are crucial but far from comprehensive, 
especially in the context of HIV, HCV, TB and 
harm reduction.
It is important to mention that while the 
SPT has the mandate and the professional 
expertise to monitor HIV, HCV, TB and harm 
reduction in prisons, it struggles significantly 
from a shortage of both human and financial 
resources, which inhibits the fulfilment of its 
mandate.113 In 2012, for example, the SPT was 
only able to conduct two visits while having 
65 states parties. This suggests a rate of one 
country visit every twenty years, which, in its 
own words, “is not compatible with the spirit 
of conducting regular visits and on-going 
dialogue”.114 This lack of resources, both 
financial and human, will need to be addressed 
in a sustainable manner for the SPT to be able 
to effectively fulfil its mandate, including in the 
context of HIV, HCV, TB and harm reduction.
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Conclusions and recommendations
Prisoners retain their human rights during 
incarceration, including their right to the 
highest attainable standard of health. There 
is an enormous gap, however, between 
public health and human rights standards and 
effective implementation in places of detention. 
Statistics revealing the high incidence rates 
inside prisons compared to those in the 
broader community, for example, demonstrate 
that this is particularly the case with regards 
to HIV, HCV and TB. Despite their vulnerability 
to ill health, prisoners are much less likely to 
have access to adequate prevention, care and 
treatment of these diseases, including harm 
reduction services. Additionally, prisoners 
are often held in substandard conditions that 
favour the transmission of diseases.
As this report has demonstrated, the right 
to health and the right to be free from ill 
treatment are increasingly recognised as being 
interrelated and indivisible, especially in prison 
contexts, by UN mechanisms, courts and 
prison monitoring bodies. Indeed, as the former 
Special Rapporteur on the right to health has 
noted, “[t]he promotion and protection of the 
right to health…strengthens the prevention of 
torture and ill-treatment, while the prohibition 
of torture…reinforces the realisation of the 
right to health.”115 With a broad preventive 
mandate and unrestricted access to all places 
of detention, prison monitoring bodies such as 
the CPT and SPT, as well as National Preventive 
Mechanisms, are in a unique position to help 
prevent ill treatment while promoting and 
protecting prisoners’ right to health.
On the whole, the CPT and the SPT both 
have the mandate and the expertise to 
monitor issues relating to HIV, HCV, TB and 
harm reduction in prisons. In practice, while 
concrete steps are being taken to fulfil this part 
of their mandate, especially with regards to 
the CPT which has more resources, capacity 
and experience, more could be done by both 
mechanisms to strengthen protection from 
ill treatment in this particular context, while 
contributing to improved health and enjoyment 
of human rights for prisoners.
RECOMMENDATIONS fOR THE CPT AND 
SPT
1. Ensure consistency when setting 
rules and standards with regards to 
HIV, HCV, TB and harm reduction in 
recommendations.
More could be done to ensure cohesion 
between the CPT and SPT with regards to 
the examination of, and recommendations 
on, HIV, HCV, TB and harm reduction in 
prisons. While there do not appear to 
be any conflicting recommendations or 
standards promoted, the SPT does not 
ever go as far as the CPT. The SPT echoes 
many of the CPT’s recommendations in the 
context of health more generally but, as 
already discussed, the SPT could follow 
the CPT’s example and focus more of its 
attention on issues relating to HIV, HCV, TB 
and harm reduction in particular. The CPT 
and SPT should consult and cooperate 
to promote their objectives in an effective 
way, as encouraged by the OPCAT.116
2. Undertake targeted visits on HIV, HCV, 
TB and harm reduction in prisons.
Targeted visits examining these and related 
issues in depth would be one of the most 
effective ways of adopting a systematic and 
comprehensive approach to monitoring 
HIV, HCV, TB and harm reduction in prisons. 
This supports a statement expressed by 
the CPT that “there is a generally held view 
within the Committee that it must seek to 
give sharper focus to many of its visits and 
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make them more targeted.”117 However, 
given the magnitude of the problem posed 
by HIV, HCV and TB in prisons, in both 
public health and human rights terms, 
these targeted visits should be undertaken 
with the intent of becoming integrated into 
regular visits with time.
3. Use Harm Reduction International’s 
monitoring tool, Monitoring HIV, HCV, 
TB and Harm Reduction in Prisons: A 
Human Rights-Based Tool to Prevent 
Ill Treatment, in part or in whole, during 
targeted or regular visits.
This could be beneficial for several 
reasons. First, it would help to ensure that 
a systematic and comprehensive approach 
to monitoring these issues is taken, and that 
recommendations stemming from visits are 
more consistent. Second, it would allow for 
the standardised collection of objective, 
reliable and comparable data on HIV, HCV 
and TB and harm reduction in prisons, 
which is currently sparse, on a national, 
regional and global scale. Third, it would 
simplify the identification of situations that 
could amount to ill treatment in the context 
of HIV, HCV, TB and harm reduction, 
while also contributing to the progressive 
realisation of other human rights, including 
the right to health. As a human rights-based 
approach requires the disaggregation of 
data, this monitoring tool would also allow 
the identification of especially vulnerable 
groups or any situations of discrimination. 
Further, it would send a strong message 
to government and prison authorities 
about the importance of harm reduction in 
prisons, as well as preventing, treating and 
caring for HIV, HCV, TB in a human rights-
compliant manner.
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Harm Reduction International is an international 
non-governmental organisation that works to reduce 
drug-related harms by promoting evidence-based 
public health policy and practices, and human 
rights based approaches to drug policy through 
an integrated programme of research, analysis, 
advocacy and civil society strengthening. Our vision 
is a world in which individuals and communities 
benefit from drug laws, policies and practices that 
promote health, dignity and human rights.
People who inject drugs make up about one third to one half of prison populations globally, 
and prisons have a much higher prevalence of HIV, hepatitis C (HCV) and TB than the broader 
community. yet the provision of harm reduction services continues to remain extremely 
limited in prisons in comparison to what is available in the broader community. This has 
serious public health and human rights implications, which should be considered by human 
rights-based prison monitoring mechanisms. 
This report identifies some of the most important human rights and public health standards relating 
to HIV, HCV, TB and harm reduction in prisons, demonstrating the indivisibility and interdependence 
of the right to the highest attainable standard of physical and mental health and the freedom from 
torture or cruel, inhuman or degrading treatment or punishment. A review of the mandate and 
working practice of European and international human rights-based prison monitoring mechanisms 
highlights that they are in a unique and critical position to consider these important issues, although 
this is not yet occurring in an adequately systematic or comprehensive manner.
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